EMEA (Europe, Middle East and Africa) Hemophilia Drugs Market Report 2017

August 2017 | 129 pages | ID: E153334E378EN
QYResearch

Abstracts

In this report, the EMEA Hemophilia Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Hemophilia Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hemophilia Drugs market competition by top manufacturers/players, with Hemophilia Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxalta
• Bayer
• CSL Behring
• Novo Nordisk
• Pfizer
• Roche
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Asklepios BioPharmaceutical
• Biogen
• BioMarin
• Catalyst Bioscience
• Chiesi Farmaceutici
• Dimension Therapeutics
• Emergent BioSolutions
• Grifols, Kedrion Biopharma
• Octapharma
• rEVO Biologics
• OPKO Biologics
• Sangamo Biosciences
• Spark Therapeutics
• Swedish Orphan Biovitrum
• UniQure Biopharma.

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

• Hemophilia A
• Hemophilia B
• Hemophilia C

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Hemophilia Drugs for each application, including

• Clinic
• Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Hemophilia Drugs Market Report 2017

1 HEMOPHILIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Hemophilia Drugs
1.2 Classification of Hemophilia Drugs
  1.2.1 EMEA Hemophilia Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Hemophilia Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Hemophilia A
  1.2.4 Hemophilia B
  1.2.5 Hemophilia C
1.3 EMEA Hemophilia Drugs Market by Application/End Users
  1.3.1 EMEA Hemophilia Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
1.4 EMEA Hemophilia Drugs Market by Region
  1.4.1 EMEA Hemophilia Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Hemophilia Drugs (2012-2022)
  1.5.1 EMEA Hemophilia Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Hemophilia Drugs Revenue and Growth Rate (2012-2022)

2 EMEA HEMOPHILIA DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Hemophilia Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Hemophilia Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Hemophilia Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Hemophilia Drugs Sale Price by Players (2012-2017)
2.2 EMEA Hemophilia Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Hemophilia Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Hemophilia Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Hemophilia Drugs Sale Price by Type (2012-2017)
2.3 EMEA Hemophilia Drugs (Volume) by Application
2.4 EMEA Hemophilia Drugs (Volume and Value) by Region
  2.4.1 EMEA Hemophilia Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Hemophilia Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Hemophilia Drugs Sales Price by Region (2012-2017)

3 EUROPE HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Hemophilia Drugs Sales and Value (2012-2017)
  3.1.1 Europe Hemophilia Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Hemophilia Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Hemophilia Drugs Sales and Market Share by Type
3.3 Europe Hemophilia Drugs Sales and Market Share by Application
3.4 Europe Hemophilia Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Hemophilia Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Hemophilia Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Hemophilia Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Hemophilia Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Hemophilia Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Hemophilia Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Hemophilia Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Hemophilia Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Hemophilia Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Hemophilia Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Hemophilia Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Hemophilia Drugs Sales and Market Share by Type
4.3 Middle East Hemophilia Drugs Sales and Market Share by Application
4.4 Middle East Hemophilia Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Hemophilia Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Hemophilia Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Hemophilia Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Hemophilia Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Hemophilia Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Hemophilia Drugs Sales and Growth Rate (2012-2017)

5 AFRICA HEMOPHILIA DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Hemophilia Drugs Sales and Value (2012-2017)
  5.1.1 Africa Hemophilia Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Hemophilia Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Hemophilia Drugs Sales and Market Share by Type
5.3 Africa Hemophilia Drugs Sales and Market Share by Application
5.4 Africa Hemophilia Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Hemophilia Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Hemophilia Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Hemophilia Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Hemophilia Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Hemophilia Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Hemophilia Drugs Sales and Growth Rate (2012-2017)

6 EMEA HEMOPHILIA DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Baxalta
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hemophilia Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxalta Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hemophilia Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Behring
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hemophilia Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Behring Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novo Nordisk
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hemophilia Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novo Nordisk Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hemophilia Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hemophilia Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Alnylam Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hemophilia Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Alnylam Pharmaceuticals Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Amarna Therapeutics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Hemophilia Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Amarna Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Asklepios BioPharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Hemophilia Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Asklepios BioPharmaceutical Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Biogen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Hemophilia Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biogen Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BioMarin
6.12 Catalyst Bioscience
6.13 Chiesi Farmaceutici
6.14 Dimension Therapeutics
6.15 Emergent BioSolutions
6.16 Grifols, Kedrion Biopharma
6.17 Octapharma
6.18 rEVO Biologics
6.19 OPKO Biologics
6.20 Sangamo Biosciences
6.21 Spark Therapeutics
6.22 Swedish Orphan Biovitrum
6.23 UniQure Biopharma.

7 HEMOPHILIA DRUGS MANUFACTURING COST ANALYSIS

7.1 Hemophilia Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hemophilia Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hemophilia Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HEMOPHILIA DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Hemophilia Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Hemophilia Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Hemophilia Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Hemophilia Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Hemophilia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Hemophilia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Hemophilia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Hemophilia Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Hemophilia Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Hemophilia Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hemophilia Drugs
Figure EMEA Hemophilia Drugs Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Hemophilia Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Hemophilia A Product Picture
Figure Hemophilia B Product Picture
Figure Hemophilia C Product Picture
Figure EMEA Hemophilia Drugs Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Hemophilia Drugs by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure EMEA Hemophilia Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hemophilia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Hemophilia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Hemophilia Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Hemophilia Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Hemophilia Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Hemophilia Drugs Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Hemophilia Drugs Sales Share by Players (2012-2017)
Figure 2016 Hemophilia Drugs Sales Share by Players
Figure 2017 Hemophilia Drugs Sales Share by Players
Figure EMEA Hemophilia Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Hemophilia Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Hemophilia Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Hemophilia Drugs Revenue Share by Players
Table 2017 EMEA Hemophilia Drugs Revenue Share by Players
Table EMEA Hemophilia Drugs Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Hemophilia Drugs Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Hemophilia Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Hemophilia Drugs by Type (2012-2017)
Figure EMEA Hemophilia Drugs Sales Market Share by Type (2012-2017)
Table EMEA Hemophilia Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Hemophilia Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hemophilia Drugs by Type in 2016
Table EMEA Hemophilia Drugs Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Hemophilia Drugs Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Hemophilia Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Hemophilia Drugs by Application (2012-2017)
Figure EMEA Hemophilia Drugs Sales Market Share by Application in 2016
Table EMEA Hemophilia Drugs Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Hemophilia Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Hemophilia Drugs by Region (2012-2017)
Figure EMEA Hemophilia Drugs Sales Market Share in 2016
Table EMEA Hemophilia Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Hemophilia Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Hemophilia Drugs by Region (2012-2017)
Figure EMEA Hemophilia Drugs Revenue Market Share Regions in 2016
Table EMEA Hemophilia Drugs Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Hemophilia Drugs Revenue and Growth Rate (2012-2017)
Table Europe Hemophilia Drugs Sales (K MT) by Type (2012-2017)
Table Europe Hemophilia Drugs Market Share by Type (2012-2017)
Figure Europe Hemophilia Drugs Market Share by Type in 2016
Table Europe Hemophilia Drugs Sales (K MT) by Application (2012-2017)
Table Europe Hemophilia Drugs Market Share by Application (2012-2017)
Figure Europe Hemophilia Drugs Market Share by Application in 2016
Table Europe Hemophilia Drugs Sales (K MT) by Countries (2012-2017)
Table Europe Hemophilia Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Hemophilia Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Hemophilia Drugs Sales Market Share by Countries in 2016
Table Europe Hemophilia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Hemophilia Drugs Revenue Market Share by Countries in 2016
Figure Germany Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure France Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UK Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Hemophilia Drugs Sales (K MT) by Type (2012-2017)
Table Middle East Hemophilia Drugs Market Share by Type (2012-2017)
Figure Middle East Hemophilia Drugs Market Share by Type (2012-2017)
Table Middle East Hemophilia Drugs Sales (K MT) by Applications (2012-2017)
Table Middle East Hemophilia Drugs Market Share by Applications (2012-2017)
Figure Middle East Hemophilia Drugs Sales Market Share by Application in 2016
Table Middle East Hemophilia Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Hemophilia Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Hemophilia Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Hemophilia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Hemophilia Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Hemophilia Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Hemophilia Drugs Sales (K MT) by Type (2012-2017)
Table Africa Hemophilia Drugs Sales Market Share by Type (2012-2017)
Figure Africa Hemophilia Drugs Sales Market Share by Type (2012-2017)
Figure Africa Hemophilia Drugs Sales Market Share by Type in 2016
Table Africa Hemophilia Drugs Sales (K MT) by Application (2012-2017)
Table Africa Hemophilia Drugs Sales Market Share by Application (2012-2017)
Figure Africa Hemophilia Drugs Sales Market Share by Application (2012-2017)
Table Africa Hemophilia Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Africa Hemophilia Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Hemophilia Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Hemophilia Drugs Sales Market Share by Countries in 2016
Table Africa Hemophilia Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Hemophilia Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Hemophilia Drugs Revenue Market Share by Countries in 2016
Figure South Africa Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Table Baxalta Hemophilia Drugs Basic Information List
Table Baxalta Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Baxalta Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Baxalta Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Baxalta Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer Hemophilia Drugs Basic Information List
Table Bayer Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Bayer Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table CSL Behring Hemophilia Drugs Basic Information List
Table CSL Behring Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure CSL Behring Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure CSL Behring Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure CSL Behring Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Hemophilia Drugs Basic Information List
Table Novo Nordisk Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novo Nordisk Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Novo Nordisk Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Hemophilia Drugs Basic Information List
Table Pfizer Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Roche Hemophilia Drugs Basic Information List
Table Roche Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Roche Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Roche Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Alnylam Pharmaceuticals Hemophilia Drugs Basic Information List
Table Alnylam Pharmaceuticals Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Alnylam Pharmaceuticals Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Amarna Therapeutics Hemophilia Drugs Basic Information List
Table Amarna Therapeutics Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amarna Therapeutics Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Amarna Therapeutics Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Amarna Therapeutics Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Asklepios BioPharmaceutical Hemophilia Drugs Basic Information List
Table Asklepios BioPharmaceutical Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Asklepios BioPharmaceutical Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Asklepios BioPharmaceutical Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Asklepios BioPharmaceutical Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table Biogen Hemophilia Drugs Basic Information List
Table Biogen Hemophilia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biogen Hemophilia Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Biogen Hemophilia Drugs Sales Market Share in EMEA (2012-2017)
Figure Biogen Hemophilia Drugs Revenue Market Share in EMEA (2012-2017)
Table BioMarin Hemophilia Drugs Basic Information List
Table Catalyst Bioscience Hemophilia Drugs Basic Information List
Table Chiesi Farmaceutici Hemophilia Drugs Basic Information List
Table Dimension Therapeutics Hemophilia Drugs Basic Information List
Table Emergent BioSolutions Hemophilia Drugs Basic Information List
Table Grifols, Kedrion Biopharma Hemophilia Drugs Basic Information List
Table Octapharma Hemophilia Drugs Basic Information List
Table rEVO Biologics Hemophilia Drugs Basic Information List
Table OPKO Biologics Hemophilia Drugs Basic Information List
Table Sangamo Biosciences Hemophilia Drugs Basic Information List
Table Spark Therapeutics Hemophilia Drugs Basic Information List
Table Swedish Orphan Biovitrum Hemophilia Drugs Basic Information List
Table UniQure Biopharma. Hemophilia Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemophilia Drugs
Figure Manufacturing Process Analysis of Hemophilia Drugs
Figure Hemophilia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2016
Table Major Buyers of Hemophilia Drugs
Table Distributors/Traders List
Figure EMEA Hemophilia Drugs Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Hemophilia Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Hemophilia Drugs Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Hemophilia Drugs Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Hemophilia Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Hemophilia Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Hemophilia Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Hemophilia Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Hemophilia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Hemophilia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Hemophilia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Hemophilia Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Hemophilia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Hemophilia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Hemophilia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Hemophilia Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Hemophilia Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Hemophilia Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Hemophilia Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Hemophilia Drugs Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Hemophilia Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Hemophilia Drugs Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Hemophilia Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources